Focused Wealth Management, Inc Bristol Myers Squibb CO Transaction History

Focused Wealth Management, Inc

$699 Million
Q2 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$47.98 - $54.4 $18,664 - $21,161	389 Added 7.26%	5,746 $311,000
Q4 2023 Jan 10, 2024	SELL	$48.48 - $57.85 $27,585 - $32,916	-569 Reduced 9.6%	5,357 $274,000
Q3 2023 Nov 01, 2023	BUY	$57.89 - $64.73 $1,273 - $1,424	22 Added 0.37%	5,926 $343,000
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $4,459 - $4,951	70 Added 1.2%	5,904 $377,000
Q1 2023 Apr 13, 2023	SELL	$65.71 - $74.53 $2,694 - $3,055	-41 Reduced 0.7%	5,834 $404,000
Q4 2022 Jan 13, 2023	BUY	$68.48 - $81.09 $1,095 - $1,297	16 Added 0.27%	5,875 $0
Q3 2022 Oct 20, 2022	BUY	$0.13 - $76.84 $2 - $1,306	17 Added 0.29%	5,859 $417,000
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $653 - $719	9 Added 0.15%	5,842 $450,000
Q1 2022 Apr 29, 2022	SELL	$61.48 - $73.72 $158,802 - $190,418	-2,583 Reduced 30.69%	5,833 $426,000
Q4 2021 Jan 31, 2022	BUY	$53.63 - $62.52 $27,887 - $32,510	520 Added 6.59%	8,416 $525,000
Q3 2021 Oct 12, 2021	BUY	$59.17 - $69.31 $1,420 - $1,663	24 Added 0.3%	7,896 $467,000
Q2 2021 Jul 15, 2021	BUY	$61.91 - $67.42 $2,166 - $2,359	35 Added 0.45%	7,872 $526,000
Q1 2021 May 03, 2021	BUY	$59.34 - $66.74 $25,041 - $28,164	422 Added 5.69%	7,837 $495,000
Q4 2020 Feb 03, 2021	SELL	$57.74 - $65.43 $25,232 - $28,592	-437 Reduced 5.57%	7,415 $460,000
Q3 2020 Oct 19, 2020	BUY	$57.43 - $63.64 $112,849 - $125,052	1,965 Added 33.38%	7,852 $473,000
Q2 2020 Jul 24, 2020	BUY	$54.82 - $64.09 $8,880 - $10,382	162 Added 2.83%	5,887 $346,000
Q1 2020 May 06, 2020	BUY	$46.4 - $67.43 $510 - $741	11 Added 0.19%	5,725 $319,000
Q4 2019 Jan 21, 2020	SELL	$49.21 - $64.19 $7,430 - $9,692	-151 Reduced 2.57%	5,714 $367,000
Q3 2019 Nov 06, 2019	SELL	$42.77 - $50.71 $80,150 - $95,030	-1,874 Reduced 24.22%	5,865 $297,000
Q2 2019 Jul 19, 2019	SELL	$44.62 - $49.34 $12,493 - $13,815	-280 Reduced 3.49%	7,739 $351,000
Q1 2019 May 03, 2019	BUY	$45.12 - $53.8 $16,017 - $19,099	355 Added 4.63%	8,019 $383,000
Q4 2018 Jan 30, 2019	BUY	$48.76 - $63.23 $65,582 - $85,044	1,345 Added 21.29%	7,664 $398,000
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $73,568 - $82,979	1,333 Added 26.73%	6,319 $392,000
Q2 2018 Aug 15, 2018	SELL	$50.53 - $62.98 $355,680 - $443,316	-7,039 Reduced 58.54%	4,986 $276,000
Q1 2018 May 07, 2018	BUY	$59.92 - $68.98 $156,690 - $180,382	2,615 Added 27.79%	12,025 $761,000
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $299,280 - $326,292	-4,993 Reduced 34.67%	9,410 $577,000
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $182,148 - $210,214	3,298 Added 29.7%	14,403 $918,000
Q2 2017 Aug 14, 2017	BUY	N/A	11,105	11,105 $619,000

Others Institutions Holding BMY

# of Institutions

2,425

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.93 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.87 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Focused Wealth Management, Inc with notifications on news.

Account